Healthcare and entitlement reform expert Avik Roy sees two major problems in healthcare today: overly high drug prices and a bottleneck at the FDA. Progress, he argues, isn’t about health insurance but the innovation occurring in drug development. Echoing President-elect Trump, Roy would like to see more free market options to combat the rising cost of drugs, as well as a more streamlined drug-approval process.
“Nearly every dollar of growth in federal spending is driven by growth in healthcare spending.”
About Avik Roy
Avik Roy is the author of Transcending Obamacare and How Medicaid Fails the Poor. Roy is the President of the Foundation for Research on Equal Opportunity as well as the Managing Partner at Roy Healthcare Research, LLC, which provides proprietary healthcare investment and policy research to institutional investors and stakeholders. During the 2012 U.S. presidential campaign, Roy was a senior healthcare advisor to Mitt Romney, where he helped develop Romney’s agenda on healthcare and entitlement reform. He was also an advisor to Marco Rubio and Rick Perry during the 2016 campaign. From 2011 to 2016, Roy was a senior fellow at the Manhattan Institute for Policy Research. Prior to his career in healthcare policy, Roy spent more than a decade on Wall Street as a buy side analyst and portfolio manager in healthcare at institutions such as Bain Capital and J.P. Morgan. He is opinion editor at Forbes.